This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why You Should Retain American International (AIG) Stock Now
by Zacks Equity Research
Rising premiums, cost control efforts, streamlining of operations and increasing rates poise American International (AIG) well for growth.
Intercontinental (ICE), Freddie Mac Join to Enhance Loan Quality
by Zacks Equity Research
Intercontinental (ICE) and Freddie Mac collaborate to improve loan quality and reduce defects in the loan origination process.
Sun Life (SLF) Expands Family Leave Insurance Product in Florida
by Zacks Equity Research
Sun Life (SLF) bridges the gap of funding for small-size and mid-size firms, which enable them to provide paid family leave for their employees.
Are Investors Undervaluing CNO Financial Group (CNO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Compelling Reasons to Hold on to Marsh & McLennan (MMC) Stock
by Zacks Equity Research
Marsh & McLennan (MMC) gains from strong segmental contribution, better rate hikes and solid growth in operating cash flows.
CNO Financial (CNO) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
Strength Seen in James River Group (JRVR): Can Its 17.5% Jump Turn into More Strength?
by Zacks Equity Research
James River Group (JRVR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Should You Hold EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) stands to gain from reduced operating expenses, revenue growth within the health direct-to-consumer agency and a robust capital position.
Why Is American International Group (AIG) Up 9.1% Since Last Earnings Report?
by Zacks Equity Research
American International Group (AIG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Reasons to Hold Prudential Financial (PRU) in Your Portfolio Now
by Zacks Equity Research
Prudential Financial (PRU) stands to gain from growing pension risk transfer market, higher emerging markets earnings, improved spread income, strategic acquisitions and effective capital deployment.
Here's Why Investors Should Retain Everest Group (EG) Stock
by Zacks Equity Research
Everest Group (EG) stands to gain from an improved interest rate environment, strong renewal retention, continued favorable rate increases and a solid capital position.
Why Is CNO (CNO) Down 2.2% Since Last Earnings Report?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Buy CNO Financial Group (CNO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Marsh & McLennan's (MMC) Mercer SelectRx to Lower Pharmacy Spend
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit Mercer launches a tech-enabled solution to generate higher cost savings for employees on specialty drugs and subsequently, drive its revenues.
Reasons Why Assurant (AIZ) Stock is an Attractive Pick Now
by Zacks Equity Research
Assurant (AIZ) stands to gain from a well-performing Global Lifestyle business, growth of fee-based capital-light businesses, solid capital management and favorable estimates.
Why CNO Financial (CNO) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Add MGIC Investment (MTG) to Your Kitty
by Zacks Equity Research
MGIC Investment (MTG) stands to gain from solid insurance in force, a decline in loss and claims payments, better housing market fundamentals and prudent capital deployment.
Best Value Stocks to Buy for March 1st
by Zacks Equity Research
RCL, RITM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 1, 2023.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
Are Investors Undervaluing Assurant (AIZ) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Allianz (ALIZY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AIG Q4 Earnings Beat Estimates on General Insurance Strength
by Zacks Equity Research
AIG's fourth-quarter results benefit from strong underwriting results, partially offset by higher expenses.
Lincoln National (LNC) Q4 Earnings Beat on Group Protection Unit
by Zacks Equity Research
Lincoln National's (LNC) Q4 results indicate favorable Life mortality and disability results, and a decline in overall expenses, partly offset by a lower spread income within the Retirement Plan Services unit.
New Strong Buy Stocks for February 9th
by Zacks Equity Research
PBPB, FUNC, MDC, CNO and HRB have been added to the Zacks Rank #1 (Strong Buy) List on February 9, 2023.
Best Income Stocks to Buy for February 9th
by Zacks Equity Research
FUNC, MDC and CNO made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 9, 2023.